Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,030 across all filing types
Latest filing 2023-11-24 Transaction in Own Shar…
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 99% confidence The document explicitly states the subject matter is a 'Transaction in Own Shares' and details the purchase of ordinary shares by the company as part of a 'share buyback programme'. It provides specific trade details (date, volume, price) and updates the total voting rights after treasury share acquisition. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement confirming RNS as the information provider indicates it is a regulatory announcement, but the specific content points overwhelmingly to POS.
2023-11-24 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states the subject is 'Transaction in Own Shares' and details the purchase of 160,000 ordinary shares by the company as part of its 'share buyback programme'. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers company repurchases.
2023-11-23 English
Syncona to acquire Freeline Therapeutics Holdings
Delisting Announcement Classification · 99% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement disseminated via the London Stock Exchange's RNS service. The content details a significant corporate action: Syncona Limited's portfolio company entering an agreement to acquire all outstanding shares of Freeline Therapeutics Holdings plc in an all-cash transaction. This describes a takeover or merger activity. Based on the definitions, the most specific category for an announcement regarding a merger proposal or takeover bid is 'M&A Activity' (TAR). Although it is distributed via RNS, the core subject matter is M&A, making TAR the primary classification.
2023-11-22 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: "Transaction in Own Shares". It details the number of ordinary shares purchased by the company on a specific date (21 November 2023) as part of a previously announced share buyback programme. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers company share repurchases. The presence of the RNS Number and the closing statement confirming the information is provided by RNS (London Stock Exchange's news service) confirms it is a regulatory disclosure, but the specific content dictates the POS classification over the general RNS fallback.
2023-11-22 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: "Transaction in Own Shares". It details the number of ordinary shares purchased by the Company on a specific date (20 November 2023) as part of a previously announced share buyback programme. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers the company buying back its own shares (share repurchase). The presence of the RNS Number and the closing statement confirming the information is provided by RNS suggests it is a regulatory announcement, but the core subject matter is the share repurchase itself, making POS the most specific classification.
2023-11-21 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states the subject is 'Transaction in Own Shares' and details the purchase of Ordinary Shares by the Company as part of a 'share buyback programme'. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). Although it is distributed via RNS, the specific content dictates the POS classification over the general RNS fallback. The document length is relatively short (3238 chars), but the content is a specific transaction report, not an announcement *about* a report.
2023-11-20 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.